Abdalla Deb, Consultant Urologist and Faculty Member in Arab Association of Urology (AAU) and Arabic-British urological society (ABUS), shared on X:
“Fascinating meeting in Busan on adjuvant immunotherapy in high-risk RCC, chaired by Chang Wook Jeong
CheckMate-214 → 5-yr OS 42% vs 26% KEYNOTE-564 → DFS HR 0.68 Talks were in Korean – but the science and hospitality were universally clear.”
More posts about Immunotherapy.
